Neurotech shares jump 25% as chairman speaks of ‘considerable opportunity’ by Steve Jones August 27, 2026August 27, 2026 Shares in drug development firm Neurotech International opened 25% higher today as it spruiked its progress […]
Neurotech to release paediatric cannabis drug through Authorised Prescribers by Adam Sheldon September 24, 2025February 21, 2026
Family experience of MC drives Medibis to fund autism anxiety trial by Adam Sheldon August 5, 2025August 19, 2025
Financial news in brief: Elixinol reassures ASX over financing; NTI shuts down two subsidiaries by Steve Jones August 1, 2025August 1, 2025
Neurotech seeks pharma partners for overseas drug development but will go it alone in Australia by Steve Jones August 12, 2024August 12, 2024
Neurotech reports strong trial results as firm raises A$10m to fund drug-registration activities by Steve Jones April 17, 2024April 18, 2024
Medibis embarks on fresh capital raise ahead of autism clinical trial by Steve Jones February 23, 2024February 28, 2024
